Research shows at home exercise improves movement symptoms Date 19 September 2019 Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
Caption Person with Parkinson's talking about PIP with a local adviser Waiting times for PIP appeals increase again Date 17 September 2019 New data shows that some people waiting to get Personal Independence Payments has increased to over a year
Prostate drug shows promise in Parkinson’s Date 17 September 2019 A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Caption Ronan Coyle on the golf course Golf helps my Parkinson’s Date 10 September 2019 Young golfer finds exercise helps him with his symptoms
Our new chair of the Board of Trustees Date 5 September 2019 Mark Goodridge will retire as chair in October, and Gary Shaughnessy has been elected as his successor
Hormone treatment slows Parkinson's symptoms in mice Date 20 August 2019 Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
New device improves Parkinson’s symptoms Date 25 July 2019 Researchers have shown that an ‘easy to use’ portable stimulation headset may be able to reduce both motor and non-motor symptoms of Parkinson’s.
Welfare is unfair, says new report Date 16 July 2019 A new report from the Disability Benefits Consortium shows how changes to the benefits system have had a devastating impact on disabled people.
New research puts serotonin at the heart of Parkinson’s Date 20 June 2019 In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
HYPE protein found to target alpha-synuclein Date 19 June 2019 Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
